Results 101 to 110 of about 6,025 (196)

Comparative Analysis of Tenecteplase versus Alteplase in Acute Ischemic Stroke: A Multicentric Observational Study from Eastern India

Annals of Indian Academy of Neurology
Background: Tenecteplase is used as an alternative to alteplase and is considered noninferior for thrombolysis in acute ischemic stroke. Objectives: To compare the effectiveness and adverse effects of tenecteplase and alteplase in the real-world ...
Arpan Dutta, Subhadeep Gupta, Uddalak Chakraborty, Chayan Mondal, Soumozit Banerjee, Deep Das, Sanat K. Jatua, Susanta Chakrabarty, Samiran Misra, Jishnu Bhattacharya, Samir K. Datta, Somnath Ghosh, Debasish Sanyal, Arnab Sarkar, Biman K. Ray   +14 more
doaj   +1 more source

Antiagregación y anticoagulación en síndromes coronarios agudos: niveles de evidencia [PDF]

, 2007
Management of acute coronary syndromes (ACS) has moved rapidly in parallel with our understanding of the pathophysiological basis of the disease. In the eighties, the demonstration of the pivotal role of coronary thrombosis in the etiology of a ACS led ...
Garcia, R. (R.), Paramo, J.A. (José Antonio), Rodriguez, P. (P.), Ruiz-de-Gaona, E. (Estefanía)   +3 more
core  

Чому атеросклероз однаково безжальний до судин мозку та серця? [PDF]

, 2011
Рассмотрены современные представления об атеросклерозе с позиций определяющей роли нарушений липидного обмена и порождаемого ими воспалительного процесса. Обсуждается природа преимущественной клинической манифестации атеросклероза сосудов сердца и мозга.
Бичкова, О.Ю., Каменська, Е.П., Крайз, І.Г., Лисенко, Н.В., Макієнко, Н.В., Мартим’янова, Л.О., Яблучанський, М.І.   +6 more
core  

Successful thrombolysis of a thrombosed prosthetic mitral valve using a synthetic tissue plasminogen activator: a case report [PDF]

, 2010
Nael Al-Sarraf, Fahad Al-Shammari, Jamal Al-Fadhli, Emad Al-Shawaf   +3 more
core   +1 more source

Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions. [PDF]

, 2016
Intravitreal recombinant tissue plasminogen activator (rtPA) is used off-label for the surgical management of submacular hemorrhage, a severe complication of neovascular age-related macular degeneration.
Behar-Cohen, F., Berdugo, M., Crisanti, P., Daruich, A., Delaunay, K., Le Rouzic, Q., Naud, M.C., Parcq, J., Picard, E., Vivien, D.   +9 more
core   +1 more source

Tenecteplase versus standard care in patients with acute basilar artery occlusion: a multi-centre, prospective, randomised, open-label, blinded endpoint, phase 3, controlled trial

Stroke and Vascular Neurology
Background and purpose There is a scarcity of evidence of tenecteplase administered within the 24-hour window of acute ischaemic stroke due to basilar artery occlusion (BAO).
Bruce C V Campbell, Yongjun Wang, Yunyun Xiong, Lee H Schwamm, Mark Parsons, Marc Fisher, Fana Alemseged, Zhixin Cao, Shuangzhe Wu   +8 more
doaj   +1 more source

PCV99 Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada [PDF]

, 1926
Mallow, P.J., Hsiao, C.W., Rizzo, J.A.
core   +1 more source

Tenecteplase vs alteplase as bridging thrombectomy in ischemic stroke patients: a systematic review and meta analysis

The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
Background Alteplase (ALT) is the standard medical therapy, and also approved by food and drug administration (FDA) for acute ischemic stroke (AIS) patients who present within 4.5 h of symptom onset.
Salim Harris, Al Rasyid, Mohammad Kurniawan, Rakhmad Hidayat, Taufik Mesiano, David Pangeran, Marcellinus Michael   +6 more
doaj   +1 more source

A system-level approach for deciphering the transcriptional response to prion infection [PDF]

, 2017
Motivation: Deciphering the response of a complex biological system to an insulting event, at the gene expression level, requires adopting theoretical models that are more sophisticated than a one-to-one comparison (i.e. t-test). Here, we investigate the
Altafini, Claudio, Legname, Giuseppe, Segrè, Daniel, Zampieri, Mattia   +3 more
core  

Advances in emerging therapies 2009 [PDF]

, 2010
Lees, K.R., McArthur, K.
core   +1 more source